kalshi Science and Technology

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?

Before October 2027
Closes Oct 01, 2027 (439d) 24h volume 4 Open interest 1.0K Event When will the FDA approve Compass Pathways' COMP360 Psilocybin?
82%
implied YES probability

Price history

Last 18 days · High 87% · Low 45% · 7d -11.5pp
87%45%

Other outcomes in this event

Related stocks

Trade on Kalshi

Open on Kalshi
Frenzy Capital does not execute trades on prediction markets — we aggregate public order-book and trading data for analysis.

Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.